Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

NIH 49INDUSTRY 7OTHER 5NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Dermatologic 1

Conditions

Sarcoma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma 1

Interventions

Radiotherapy 299Cisplatin 263Cyclophosphamide 229Doxorubicin 176Paclitaxel 167Vincristine 160Carboplatin 150Filgrastim 139Etoposide 139Gemcitabine 118Fluorouracil 113Docetaxel 112Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 91Leucovorin 90Granulocyte Colony-Stimulating Factor 74Specimen Handling 66Magnetic Resonance Spectroscopy 62Capecitabine 59Irinotecan 58Radiation 54Ifosfamide 51Oxaliplatin 48Daunorubicin 48Temozolomide 47Radiotherapy, Conformal 47Platinum 47Peripheral Blood Stem Cell Transplantation 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Interventional × alvocidib × Clear all
NCT00005074 2020-04-09

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

Canadian Cancer Trials Group

Phase 2 Completed
33 enrolled
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00005971 2020-04-09

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Canadian Cancer Trials Group

Phase 2 Completed
17 enrolled
Dermatologic

Melanoma

NCT00005974 2020-04-08

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Canadian Cancer Trials Group

Phase 2 Completed
18 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡